Gene Query: RNF4

Dataset Description Geneva Score
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 40.42
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 40.2
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 37.49
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 36.56
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 32.33
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 30.48
Knockdown of ADNP in HCT116 colon cancer cells 26.61
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 26.49
RIG-I and MDA5 fRIP during KSHV lytic reactivation 25.99
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 24.88
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 23.13
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 21.97
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 18.89
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 18.24
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 17.01
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 16.54
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 16.14
Identification of global XBP1s target gene expression in human prostate cancer cells 16.07
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 15.66
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 15.46
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 14.98
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.98
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 14.3
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 14.17
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 14.1
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 13.75
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 13.63
Human Treg NaCl stimulation 13.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 13.48
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 13.43
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 13.43
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 13.27
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 13.26
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 12.69
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 12.63
Transcriptome of diurnal human blood neutrophils 11.91
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.83
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.83
The comparison of high-throughput single-cell RNA-seq methods 11.81
STRIPAK directs PP2A activity to promote oncogenic transformation 11.78
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 11.74
RNA-seq of shEZH2 cells 11.73
Tracking of dCas9-methyltransferase footprints 11.23
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 11.18
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 11.06
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.86
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.73
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 10.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 10.38
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 10.19
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 9.98
Genome wide miR-191 target profile determined by RIP and gene expression profiling 9.91
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 9.91
RNA-seq analysis of BAP1-depleted uveal melanoma cells 9.81
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 9.71
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 9.71
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.71
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.7
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 9.45
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 9.16
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 9.16
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 9.12
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 9.08
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.95
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 8.93
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 8.93
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 8.89
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 8.89
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.75
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.73
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 8.71
TOP2B disturbed the quality of human oocytes with advanced maternal age 8.59
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 8.57
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.53
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.35
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.13
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.13
8.11
Paxillin regulates genomic networks in prostate cancer [C4-2] 8.07
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 8.06
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.99
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 7.99
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.91
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 7.87
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.87
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 7.79
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.72
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.72
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 7.72
4sU-seq of HFF exposed to salt and heat stress 7.66
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.63
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 7.6
SETBP1-WT and SETBP1-G870S epigenetic landscapes 7.6
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 7.58
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.57
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.53
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 7.46
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 7.4
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.27
Effect of mitochondria deficiency on senescence-associated gene expression 7.25
Intrahepatic MAIT cell gene expression revealed by RNA-seq 7.2
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 7.17
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 7.15
Identification of HOXB13 target genes responsive to BET inhibitors 7.09
Differential expression of genes in AD169-infected MRC5. 7.07
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.03
Transcriptomic analysis of LSD1 7.0
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.99
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 6.97
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.91
Effect of drugs on transcriptomic profiles 6.9
Unique features and clinical importance of acute alloreactive immune responses 6.87
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 6.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 6.83
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.82
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 6.81
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 6.78
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.77
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.77
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.77
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.77
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.74
Downregulation of DDX5/DDX17 and REST 6.66
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 6.65
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 6.56
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 6.56
UV_24h_GRO-Seq 6.55
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.51
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.51
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.49
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.48
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.47
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.46
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.4
Short and Long RNA sequencing of human mature erythrocytes 6.39
A code of mono-phosphorylation modulates the function of RB. 6.39
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.38
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.38
Genome wide expression change in LCC2 and MCF-7 cells 6.36
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.36
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.36
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 6.31
MYC dependent mRNA translation shapes gene expression and cell biology 6.31
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 6.3
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.3
FBXW7 modulates stress response by post-translational modification of HSF1 6.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.27
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.23
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.23
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 6.22
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 6.22
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 6.18
SLIGRL-induced gene expression changes in NHEK cells 6.15
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.12
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.11
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.07
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.05
High-throughput sequencing of pluripotent cells 6.04
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 6.02
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.01
FOXD3 is a novel tumor suppressor in lung cancer 6.01
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.99
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 5.99
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.96
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.96
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.95
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.94
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 5.9
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.89
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 5.86
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.82
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.82
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 5.81
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.8
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 5.8
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.79
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.78
BCL11B 5.76
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.74
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.74
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.7
Primary human trophoblast from term placenta 5.69
Gene expression changes after LOC550643 silencing 5.69
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.68
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 5.66
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 5.65
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 5.65
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.64
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.62
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 5.61
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 5.61
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 5.61
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 5.61
The Genomic Landscape of Atypical Fibroxanthoma 5.59
mRNA expression in human DAOY cells 5.59
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.58
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.56
Lipid degradation promotes prostate cancer cell survival 5.55
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 5.54
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.52
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.52
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 5.5
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 5.5
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.48
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 5.47
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 5.45
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 5.45
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.45
Transcriptome analysis of CNS leukemia 5.41
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 5.41
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.36
Zone dependent distinctive gene expression profile of the normal human liver tissue 5.31
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.28
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.28
Effect of PRDM11 depletion in U2932 cells 5.27
A role for ZNF598 in post-transcriptional gene regulation 5.25
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 5.19
Transcriptome sequencing of K-562 cells 5.18
Global transcriptome analysis of HAP1 cells 5.17
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.15
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 5.15
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 5.13
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 5.12
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.11
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.08
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.99
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.99
Expression by CD133+ cells isolated from the adult human exocrine pancreas 4.98
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.98
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.96
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.94
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.93
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.93
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.92
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.92
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.81
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 4.78
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.77
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.77
Seletive inhibition of CDK9 in DLBCL cell lines 4.74
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.74
Determining mRNA half-lives on a transcriptome-wide scale 4.69
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.68
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.67
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.67
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.66
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.63
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.62
m6A-dependent regulation of messenger RNA stability 4.58
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.54
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.54
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.46
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.45
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.43
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.43
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.37
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.36
Cell responses to dysregulated VZV-induced cell-cell fusion 4.36
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.31
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.31
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.31
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.31
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 4.27
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.23
Stem and effector CD8 T-cells from human cancers 4.22
Gene expression signatures of innate lymphoid cells from human blood 4.2
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.14
RNA sequencing of primary human platelets and in vitro cell lines 4.13
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.09
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.08
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 4.07
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.03
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 3.98
DART-seq: an antibody-free method for global m6A detection 3.95
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.91
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.91
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.91
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 3.91
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.9
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.9
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.89
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.89
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.84
Co-regulation of splicing by Rbfox1 and hnRNP M 3.84
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.78
Global analyses of the effect of different cellular contexts on microRNA targeting 3.77
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.77
RNA expression analysis upon JMJD1C depletion 3.76
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.76
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.74
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.73
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.7
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.68
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.66
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.64
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.6
RNA-Seq from human ILC transitional populations 3.58
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.58
Global response to chemotherapy-induced apoptosis 3.57
MicroRNA targetome analysis during HCMV infection 3.56
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.55
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.53
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.53
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.53
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.52
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.49
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.49
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.49
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.47
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.46
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.45
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.44
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.44
Hepatocyte maturation 3.42
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.41
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 3.38
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 3.35
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 3.33
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.25
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.15
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.15
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 3.13
Ribosome profiling upon inhibition of eIF4A 3.12
SOX11 knockdown in B-ALL cell lines 3.08
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.07
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.04
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 3.04
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.02
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.0
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 2.93
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.89
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.87
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.85
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.84
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.84
Transcriptome-wide modulation of splicing by the exon junction complex 2.81
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.81
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.76
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.75
N6-methyladenine DNA Modification in Glioblastoma 2.75
Capturing the Interactome of Newly Transcribed RNA 2.68
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.68
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.67
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.66
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.59
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.58
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 2.57
miR-93 Targets in Human Endothelial Cells 2.55
Identification of a LIF-responsive replication-competent human β cell 2.54
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.52
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.49
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.48
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.47
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.45
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.41
High-resolution comparative analysis of great ape genomes 2.39
RNA-seq analysis of differentiating human erythroblasts 2.38
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 2.37
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.32
CD86 regulates a pro-survival signal in myeloma cells 2.32
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.31
Effect of PBK knockdown on C4-2 cell transcriptome 2.27
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.25
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.25
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.24
RNA-seq of IL-4 stimulated human keratinocytes 2.23
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.2
MicroRNA-125a-5p overexpression in human macrophages 2.16
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.14
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.09
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.09
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.07
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 2.04
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.02
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.01
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.0
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.97
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.94
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.94
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.91
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.91
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.89
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.88
DRB/GRO-Seq -/+ UV 1.86
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.84
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.83
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.83
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.81
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.79
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.79
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.79
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.76
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.76
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.75
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.74
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.73
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.72
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.68
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.68
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.65
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.65
The Genetic Landscape of Diamond-Blackfan Anemia 1.64
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.57
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.57
IMP3 regulated gene expression in breast cancer cells 1.56
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.55
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.46
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.45
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.41
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.41
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.38
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.38
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.36
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.31
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.28
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.28
Metabolism as an early predictor of DPSCs aging 1.28
NHLRC1 re-expression in cancer cells 1.28
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.26
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.23
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.23
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.23
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.23
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.22
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.19
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.19
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.15
Gene expression profile in breast cancer cells 1.15
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.15
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.15
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.13
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.11
Gene expression activation in CLL mediated by MSCs contact 1.11
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.08
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.05
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.05
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.02
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.01
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.97
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.96
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 0.93
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 0.93
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.93
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.91
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.91
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.9
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.88
RNA seq_PDX2_SHP099 0.86
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.84
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.84
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.84
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.83
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.82
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.82
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.82
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.81
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.8
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.78
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.78
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.73
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.66
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.63
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.6
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.57
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.52
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.52
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.51
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.48
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.47
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.44
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.44
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.43
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.43
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 0.41
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.37
Expression analysis of the TAF1 syndrome 0.35
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.33
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.32
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.28
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.22
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.2
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.14
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.14
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.14
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.11
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.03
Human Treg IL-12 stimulation 0.02
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.02
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.01
Function and hormonal regulation of GATA3 in human first trimester placentation 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation